Latest portfolio news

Immunexpress’ rapid test for sepsis launched in Europe on Biocartis’ Idylla platform

Debiopharm co-leads an investment round of €10 million in Oncomfort

Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers

Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID

Acquisition of Kaiku Health by the swedish company Elekta

BC Platforms Honored by Microsoft for their Efforts to “Reimagine Health” with Kaiser Permanente

Kaiku Health and the Geneva University Hospitals implement digital symptom monitoring for COVID-19 patients in Switzerland

Immunexpress and Biocartis to market a rapid sepsis triage test in the EU for COVID-19 patients

Debiopharm invests in remote cancer patient symptom monitoring for personalized care with Carevive Series C financing round